|
MAGED1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.68440000000358E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.97479999997086E-06 |
| Normal-vs-Stage2 |
7.819300E-04 |
| Normal-vs-Stage3 |
6.220600E-01 |
| Normal-vs-Stage4 |
3.641200E-04 |
| Stage1-vs-Stage2 |
4.819200E-01 |
| Stage1-vs-Stage3 |
5.680300E-02 |
| Stage1-vs-Stage4 |
6.709800E-02 |
| Stage2-vs-Stage3 |
3.180100E-02 |
| Stage2-vs-Stage4 |
1.719000E-01 |
| Stage3-vs-Stage4 |
4.024100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.001200E-04 |
| Normal-vs-AfricanAmerican |
8.44280000000808E-05 |
| Normal-vs-Asian |
8.581400E-01 |
| Caucasian-vs-AfricanAmerican |
3.039200E-01 |
| Caucasian-vs-Asian |
5.270800E-01 |
| AfricanAmerican-vs-Asian |
2.680000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.09190000041615E-07 |
| Normal-vs-Female |
8.008400E-01 |
| Male-vs-Female |
1.615100E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.427840E-02 |
| Normal-vs-Extreme_Weight |
2.57810000003911E-06 |
| Normal-vs-Obese |
5.907900E-02 |
| Normal-vs-Extreme_Obese |
1.820160E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.535800E-01 |
| Normal_Weight-vs-Obese |
4.416400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.440000E-01 |
| Extreme_Weight-vs-Obese |
4.680400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.453600E-01 |
| Obese-vs-Extreme_Obese |
2.027600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.609600E-02 |
| Normal-vs-Age(41-60Yrs) |
1.423600E-02 |
| Normal-vs-Age(61-80Yrs) |
3.52879999999667E-05 |
| Normal-vs-Age(81-100Yrs) |
4.249700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.648200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.930200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.732800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.253580E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.704600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.616600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.6563000000166E-07 |
| Normal-VS-Type2 PRCC |
9.282100E-02 |
| Normal-VS-KIRP CIMP |
3.74790198875985E-11 |
| Normal-VS-Unclassified PRCC |
9.537400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.092600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.6695000000071E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
1.169990E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.56541999999371E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
2.424000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.9433000004484E-07 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.240200E-02 |
| Normal-vs-N1 |
9.887800E-01 |
| Normal-vs-N2 |
6.524800E-01 |
| N0-vs-N1 |
4.469200E-01 |
| N0-vs-N2 |
9.556000E-01 |
| N1-vs-N2 |
7.200000E-01 |
|
|
